Kristina H. Young

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy

Kristina H. Young, Jason R. Baird, Talicia Savage et al. · PLoS ONE · 2016 · 308 citations · Full text

Immunology, Ideal Timing, Immunotherapy +17

TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking

Andrew J. Gunderson, Tomoko Yamazaki, Kayla McCarty et al. · Nature Communications · 2020 · 204 citations · Full text

Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma

Rom S. Leidner, Marka R. Crittenden, Kristina H. Young et al. · Journal for ImmunoTherapy of Cancer · 2021 · 174 citations · Full text

Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer

Andrew J. Gunderson, Venkatesh Rajamanickam, Cynthia Bui et al. · OncoImmunology · 2021 · 169 citations · Full text

Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial

Tomoko Yamazaki, Andrew J. Gunderson, Miranda Gilchrist et al. · The Lancet Oncology · 2022 · 127 citations

Surgical Oncology, Neoadjuvant Chemoradiotherapy, Radiation Therapy +9